相关实验视频

Updated: Jun 16, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

病毒感染和膀癌中的免疫调节:对免疫疗法的影响

Lívia Bitencourt Pascoal^1,2,3, Mehrsa Jalalizadeh¹, Gabriela Barbosa^1,2,3

¹UroScience, State University of Campinas, Campinas 13083-970, Brazil.

Exploration of targeted anti-tumor therapy

|April 28, 2025

概括

病毒感染可以通过改变免疫反应,显著影响膀癌的Bacillus Calmette-Guerin (BCG) 治疗的有效性. 了解这些病毒免疫相互作用是改善非肌肉侵入性膀癌 (NMIBC) 治疗结果的关键.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
病毒学病毒学

背景情况:

自1976年以来,静脉注射卡尔梅特 - 格林杆菌 (BCG) 是治疗非肌肉侵入性膀癌 (NMIBC) 的标准治疗方法.
BCG反应率的变化表明宿主免疫因素,包括病毒感染,影响疗效.
慢性病毒感染会损害T细胞的反应,导致免疫力衰竭和抗瘤免疫力降低.

研究的目的:

在NMIBC中探索病毒感染和BCG疗效之间的关系.
强调受病毒影响的免疫调节机制,影响治疗结果.
通过了解病毒影响,提出个性化策略来增强免疫疗法.

主要方法:

对有关病毒感染,免疫调节和BCG治疗的现有文献的综述.
讨论病毒载量,免疫功能障碍和瘤微环境之间的相互作用.
整合来自病毒组分析,免疫分析和瘤特征的见解.

主要成果:

慢性病毒感染可能导致免疫衰竭和抗瘤免疫力受损.
病毒抗原负荷和免疫功能障碍可以重塑瘤微环境,影响免疫治疗.
了解病毒引起的免疫失调对于优化治疗至关重要.

结论:

病毒感染是影响NMIBCBCBCG疗效的重要因素.
针对病毒诱导的免疫失调的个性化策略可能会改善免疫治疗结果.
为了更好地管理NMIBC,需要进一步研究缓解慢性感染的免疫抑制作用.

关键词:

病毒组病毒组病毒组疲疲疲疲疲免疫反应的免疫反应.衰老是一种老化.尿路细胞癌是什么意思

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...